All News

Younger Patients With Lung Cancer Often Have Targetable Biomarkers

May 19th 2025, 9:00pm

Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies, which can lead to more personalized and effective treatment.

Facing Cancer as an AYA and Navigating Fertility Preservation Choices

May 19th 2025, 8:14pm

Carly Stafford Dixon, discusses how she approached fertility preservation after her diagnosis of primary mediastinal b-cell lymphoma, a rare blood cancer.

What Patients Should Know About a Melanoma Diagnosis

May 19th 2025, 7:00pm

Melanoma care varies by stage, with early cases being treated with surgery, whereas advanced disease often requires immunotherapy or targeted therapy.

Reflecting on my Son's Graduation as a Previvor

May 19th 2025, 5:00pm

As a Lynch syndrome previvor, I feel deep gratitude to witness my son’s graduation — a milestone my brother never lived to see with his own child.

Answers to Frequently Asked Questions About Prostate Cancer Risk, Treatment

May 19th 2025, 4:00pm

Dr. Kelly Stratton answers the most frequently asked questions in prostate cancer regarding risk for recurrence, progression and treatment options.

First Patient Dosed With CX-801 Plus Keytruda in Metastatic Melanoma

May 19th 2025, 3:00pm

The first patient has received CX-801 plus Keytruda in a phase 1 trial for metastatic melanoma, aiming to assess safety and early antitumor activity.

Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

May 19th 2025, 1:00pm

Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.

Fatigue, Sleep and Urinary Symptoms Affect Cognition in Prostate Cancer

May 18th 2025, 6:00pm

Managing fatigue, sleep, urinary symptoms and depression is key to improving cognitive function in those receiving radiation therapy for prostate cancer.

Providing Care and Listening With Compassion During Cancer

May 18th 2025, 2:00pm

Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC

May 17th 2025, 6:00pm

Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.